Mid-Day Market Update: J C Penney Jumps On Strong Holiday Sales; Micron Shares Decline

Midway through trading Wednesday, the Dow traded up 0.69 percent to 17,491.24 while the NASDAQ climbed 0.81 percent to 4,629.72. The S&P also rose, gaining 0.75 percent to 2,017.55.

Leading and Lagging Sectors

On Wednesday, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Arena Pharmaceuticals ARNA and Flamel Tech. S.A. FLML.

In trading on Wednesday, basic materials shares rose by just 0.4 percent. Top decliners in the sector included RPM International Inc. RPM, down 8.8 percent, and Olympic Steel, Inc. ZEUS, off 5.2 percent.

Top Headline

Monsanto Company MON reported upbeat earnings for its first fiscal quarter.

The St. Louis, Missouri-based company posted a quarterly net profit of $243 million, or $0.50 per share, versus a year-ago profit of $368 million, or $0.69 per share. Its adjusted earnings came in at $0.47 per share.

Its sales slipped to $2.87 billion from $3.143 billion. However, analysts were expecting earnings of $0.35 per share on revenue of $2.80 billion.

Equities Trading UP

J C Penney Company Inc JCP shares shot up 17.53 percent to $7.71 on strong holiday sales. J. C. Penney reported a 3.7% y/y rise in its holiday comparable store sales. The company also announced that it now projects to report Q4 comparable store sales at the upper end of its prior outlook range of 2% to 4 percent.

Shares of Kopin Corporation KOPN got a boost, shooting up 15.18 percent to $3.88 after the company raised its 2014 sales forecast.

Arena Pharmaceuticals, Inc. ARNA shares were also up, gaining 40.48 percent to $4.66 after the company reported positive results from Phase 1b clinical trial evaluating APD334.

Equities Trading DOWN

RPM International Inc. RPM shares tumbled 8.70 percent to $44.81 after the company reported downbeat results for its fiscal 2015 second quarter and lowered its earnings forecast.

Shares of Micron Technology, Inc. MU were down 1.98 percent to $32.22 after the company reported downbeat quarterly revenue and issued a weak revenue forecast for the second quarter.

Karyopharm Therapeutics, Inc. KPTI was down, falling 5.74 percent to $31.55 after the company priced 3 million share offering at $33.00 per share.

Commodities

In commodity news, oil traded up 0.29 percent to $48.07, while gold traded down 0.37 percent to $1,214.90.

Silver traded down 0.25 percent Wednesday to $16.60, while copper fell 0.43 percent to $2.76.

Eurozone

European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.47 percent, the Spanish Ibex Index climbed 0.12 percent, while Italy’s FTSE MIB Index slipped 0.07 percent. Meanwhile, the German DAX rose 0.36 percent, and the French CAC 40 climbed 0.59 percent while UK shares jumped 0.86 percent.

Economics

The MBA reported that its index of mortgage application activity rose 11.10% in the week ended January 2, 2015.

Private-sector employers added 241,000 jobs in December, according to Automatic Data Processing Inc. However, economists were expecting an addition of 225,000 jobs.

US trade deficit declined 7.7% to $39 billion in November, versus a revised $42.2 billion in October.

The Federal Open Market Committee will issue minutes of its latest meeting at 2:00 p.m. ET.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsEurozoneCommoditiesEventsEcon #sIntraday UpdateMarkets
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...